Safety of dexmedetomidine in the cardiac intensive care unit.
Sarah K AdieNicholas FarinaAhmad A Abdul-AzizRan LeeMichael P ThomasMatthew C KonermanPublished in: European heart journal. Acute cardiovascular care (2021)
Patients admitted to the CICU experienced a high rate of adverse events with dexmedetomidine use. Those experiencing adverse events were more likely to have a higher BNP. Future studies should explore the safety of alternative sedative agents to ascertain safe pharmacological options for patients admitted to the CICU.